Brenna C McDonald

Summary

Publications

  1. ncbi Executive dysfunction following traumatic brain injury: neural substrates and treatment strategies
    Brenna C McDonald
    Department of Psychiatry, Dartmouth Medical School, Hanover, NH, USA
    NeuroRehabilitation 17:333-44. 2002
  2. ncbi Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response
    Thomas W McAllister
    Section of Neuropsychiatry, Department of Psychiatry, Dartmouth Medical School, Lebanon, NH 03756, USA
    Int J Psychophysiol 82:107-14. 2011
  3. ncbi Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury
    Thomas W McAllister
    Section of Neuropsychiatry, Department of Psychiatry, Dartmouth Medical School, Lebanon, New Hampshire 05756, USA
    J Neurotrauma 29:1111-8. 2012
  4. ncbi Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study
    Julie A Dumas
    Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA
    Menopause 17:852-9. 2010
  5. ncbi Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response
    Thomas W McAllister
    Section of Neuropsychiatry, Department of Psychiatry, Dartmouth Medical School, Lebanon, NH, USA
    J Neuropsychiatry Clin Neurosci 23:277-86. 2011
  6. ncbi Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments
    Thomas W McAllister
    Department of Psychiatry, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Curr Psychiatry Rep 6:364-71. 2004
  7. ncbi Mechanisms of working memory dysfunction after mild and moderate TBI: evidence from functional MRI and neurogenetics
    Thomas W McAllister
    Section of Neuropsychiatry, Neuropsychology Program, Brain Imaging Laboratory, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA
    J Neurotrauma 23:1450-67. 2006
  8. ncbi Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study
    Thomas W McAllister
    Department of Psychiatry, Section of Neuropsychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Brain Inj 22:705-14. 2008
  9. ncbi Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women
    Julie A Dumas
    Department of Psychiatry, Clinical Neuroscience Research Unit, University of Vermont College of Medicine, Burlington, VT 05401, USA
    Am J Geriatr Psychiatry 16:272-82. 2008
  10. ncbi Cognitive function in breast cancer patients prior to adjuvant treatment
    Tim A Ahles
    Department of Psychiatry and Center for Psycho Oncology, The Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center Lebanon, Lebanon, NH, USA
    Breast Cancer Res Treat 110:143-52. 2008

Detail Information

Publications16

  1. ncbi Executive dysfunction following traumatic brain injury: neural substrates and treatment strategies
    Brenna C McDonald
    Department of Psychiatry, Dartmouth Medical School, Hanover, NH, USA
    NeuroRehabilitation 17:333-44. 2002
    ..This review summarizes the nature of executive deficits following TBI, their neuroanatomical substrates, selected assessment and treatment strategies, and recent research findings and trends...
  2. ncbi Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response
    Thomas W McAllister
    Section of Neuropsychiatry, Department of Psychiatry, Dartmouth Medical School, Lebanon, NH 03756, USA
    Int J Psychophysiol 82:107-14. 2011
    ..On guanfacine the MTBI group showed increased activation within a WM task-specific region of interest. Findings are consistent with the hypothesis that alterations in WM after MTBI may be improved with the alpha-2 agonist guanfacine...
  3. ncbi Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury
    Thomas W McAllister
    Section of Neuropsychiatry, Department of Psychiatry, Dartmouth Medical School, Lebanon, New Hampshire 05756, USA
    J Neurotrauma 29:1111-8. 2012
    ..Polymorphisms in BDNF influence cognitive performance shortly after mTBI. The results raise the possibility that a functional polymorphism other than rs6265 may contribute to memory function after mTBI...
  4. ncbi Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study
    Julie A Dumas
    Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA
    Menopause 17:852-9. 2010
    ....
  5. ncbi Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response
    Thomas W McAllister
    Section of Neuropsychiatry, Department of Psychiatry, Dartmouth Medical School, Lebanon, NH, USA
    J Neuropsychiatry Clin Neurosci 23:277-86. 2011
    ..On bromocriptine, the MTBI group showed increased activation outside of a task-specific region of interest. Findings are consistent with the hypothesis that individuals with MTBI have altered responsivity to dopamine...
  6. ncbi Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments
    Thomas W McAllister
    Department of Psychiatry, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Curr Psychiatry Rep 6:364-71. 2004
    ..Emerging theories about the role of selected genetic polymorphisms in heightening the vulnerability to chemotherapy-induced cognitive decline will be described...
  7. ncbi Mechanisms of working memory dysfunction after mild and moderate TBI: evidence from functional MRI and neurogenetics
    Thomas W McAllister
    Section of Neuropsychiatry, Neuropsychology Program, Brain Imaging Laboratory, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA
    J Neurotrauma 23:1450-67. 2006
    ..We review the evidence from fMRI and neurogenetic studies that support the role of catecholaminergic dysregulation in the etiology of WM complaints and deficits after mild and moderate TBI...
  8. ncbi Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study
    Thomas W McAllister
    Department of Psychiatry, Section of Neuropsychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Brain Inj 22:705-14. 2008
    ....
  9. ncbi Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women
    Julie A Dumas
    Department of Psychiatry, Clinical Neuroscience Research Unit, University of Vermont College of Medicine, Burlington, VT 05401, USA
    Am J Geriatr Psychiatry 16:272-82. 2008
    ..This approach simulates the effects of age- or disease-related neuroreceptor or neuronal loss by temporarily blocking pre- and postsynaptic muscarinic and nicotinic cholinergic receptors...
  10. ncbi Cognitive function in breast cancer patients prior to adjuvant treatment
    Tim A Ahles
    Department of Psychiatry and Center for Psycho Oncology, The Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center Lebanon, Lebanon, NH, USA
    Breast Cancer Res Treat 110:143-52. 2008
    ..To compare the neuropsychological functioning of breast cancer patients with invasive cancer and noninvasive cancer prior to adjuvant treatment...
  11. ncbi FLAIR lesion volume in multiple sclerosis: relation to processing speed and verbal memory
    John J Randolph
    Brain Imaging Laboratory, Department of Psychiatry, Dartmouth Medical School, Lebanon, New Hampshire 03756 0001, USA
    J Int Neuropsychol Soc 11:205-9. 2005
    ..These findings, considered in the context of prior work, suggest that FLAIR TLV is a useful predictor of commonly impaired cognitive functions in MS, and shows promise as a functionally relevant biomarker for disease status...
  12. ncbi Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives
    Andrew J Saykin
    Brain Imaging Laboratory, Dartmouth Medical School, Lebanon, NH 03756, USA
    Semin Clin Neuropsychiatry 8:201-16. 2003
    ..Large-scale prospective studies are needed to help isolate the pathophysiological mechanisms underlying the cognitive deficits associated with chemotherapy...
  13. ncbi Recent developments in the application of the nonverbal learning disabilities model
    Brenna C McDonald
    Neuropsychology Program, Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Curr Psychiatry Rep 4:323-30. 2002
    ....
  14. ncbi Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury
    Thomas W McAllister
    Section of Neuropsychiatry, Department of Psychiatry, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756
    Am J Psychiatry 162:1749-51. 2005
    ..The authors tested the hypothesis that the dopamine D2 receptor T allele (formerly described as the A1 allele) would be associated with poorer performance on memory and attention tasks following mild traumatic brain injury...
  15. ncbi Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy
    Robert J Ferguson
    Department of Rehabilitation Medicine, Eastern Maine Medical Center, Bangor, ME 04401, USA
    J Clin Oncol 25:3866-70. 2007
    ..Late cognitive effects after chemotherapy can have a deleterious impact on survivor quality of life and functional health; however, the etiology of chemotherapy-related cognitive dysfunction remains unknown...
  16. ncbi Cognitive-behavioral management of chemotherapy-related cognitive change
    Robert J Ferguson
    Department of Rehabilitation Medicine, Eastern Maine Medical Center, Bangor, ME 04401, USA
    Psychooncology 16:772-7. 2007
    ..Given these results, the treatment appears to be a feasible and practical cognitive-behavioral program that warrants continued evaluation among cancer survivors who experience persistent cognitive dysfunction...